Longevity Research Just Hit a Tipping...
Something shifted this week. The New York Times ran a major feature piece asking whether longevity science is overhyped — and then spent 5,000 words arguing that cellular rejuvenation might...
Read MoreSomething shifted this week. The New York Times ran a major feature piece asking whether longevity science is overhyped — and then spent 5,000 words arguing that cellular rejuvenation might...
Read MoreIn the continually evolving field of longevity science, a groundbreaking study has emerged, promising to redefine our approach to aging. The biotech company Shift Biosciences, based in Cambridge, UK, has...
Read More